Su Yaming, Zhang Xiaoping, Sinko Patrick J
Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA.
Mol Pharm. 2004 Jan 12;1(1):49-56. doi: 10.1021/mp0340136.
Saquinavir mesylate (SQV) is the first-in-class and prototypical HIV protease inhibitor (PI) used in the treatment of HIV infection. SQV undergoes extensive hepatic metabolism and intestinal and bile secretion, and has poor and variable oral bioavailability. In previous studies, our group and others have described the interactions between SQV and absorptive and secretory efflux transporters such as MRP1, MRP2, and P-gp. However, the potential role of absorptive influx transporters such as OATP-A (SLC21A3) has not yet been reported for SQV. In the study presented here, the role of OATP-A in the influx transport of SQV was studied using a hepatic cell model, Hep G2, and Xenopus laevis oocytes overexpressing human OATP-A. In Hep G2 cells, SQV transport was found to be (i) concentration-dependent and saturable, (ii) temperature-sensitive, and (iii) proton (pH)- and sodium-independent. While GF120918, a specific inhibitor of P-gp, and MK571, a MRP transporter family inhibitor, significantly enhanced SQV uptake, estrone 3-sulfate, a substrate of OATP-A, significantly inhibited SQV uptake by Hep G2 cells. The observation that inhibitors of P-gp, MRP, or OATP-A have opposite effects on SQV uptake in polarized Hep G2 cells is consistent with their functions as hepatic efflux or influx transporters. In X. laevis oocytes into which OATP-A cRNA had been injected, the level of uptake of SQV was significantly greater than the level of uptake by oocytes into which water had been injected and was concentration-dependent and saturable (Km = 36.4+/-21.8 microM). This is the first report showing that SQV influx transport is directly facilitated by OATP-A. Given the wide body distribution of OATP-A, the current results suggest a potentially important role for OATP-A in the absorption and disposition of SQV in vivo. The data also suggest that in human hepatocytes basolaterally located OATP-A (influx transporter) may act in concert with apically located P-gp and/or MRP2 (efflux transporters) for the vectorial transport and excretion of SQV into bile.
甲磺酸沙奎那韦(SQV)是用于治疗HIV感染的一流且典型的HIV蛋白酶抑制剂(PI)。SQV经历广泛的肝脏代谢以及肠道和胆汁分泌,口服生物利用度差且变化不定。在先前的研究中,我们小组和其他研究小组已经描述了SQV与诸如MRP1、MRP2和P-糖蛋白等吸收性和分泌性外排转运蛋白之间的相互作用。然而,诸如OATP-A(SLC21A3)等吸收性内流转运蛋白对SQV的潜在作用尚未见报道。在本文介绍的研究中,使用肝细胞模型Hep G2和过表达人OATP-A的非洲爪蟾卵母细胞研究了OATP-A在SQV内流转运中的作用。在Hep G2细胞中,发现SQV转运具有以下特点:(i)浓度依赖性和饱和性;(ii)温度敏感性;(iii)不依赖质子(pH)和钠。虽然P-糖蛋白的特异性抑制剂GF120918和MRP转运蛋白家族抑制剂MK571显著增强了SQV的摄取,但OATP-A的底物硫酸雌酮3-酯却显著抑制了Hep G2细胞对SQV的摄取。P-糖蛋白、MRP或OATP-A的抑制剂对极化的Hep G2细胞中SQV摄取具有相反作用这一观察结果与它们作为肝脏外排或内流转运蛋白的功能一致。在注射了OATP-A cRNA的非洲爪蟾卵母细胞中,SQV的摄取水平显著高于注射了水的卵母细胞,且具有浓度依赖性和饱和性(Km = 36.4±21.8 microM)。这是首次报道表明OATP-A直接促进了SQV的内流转运。鉴于OATP-A在体内广泛的分布,目前的结果表明OATP-A在SQV体内吸收和处置中可能具有重要作用。数据还表明,在人肝细胞中,位于基底外侧的OATP-A(内流转运蛋白)可能与位于顶端的P-糖蛋白和/或MRP2(外排转运蛋白)协同作用,将SQV向胆汁进行向量转运和排泄。